227 related articles for article (PubMed ID: 32851643)
1. (±)VK4-40, a novel dopamine D
Jordan CJ; He Y; Bi GH; You ZB; Cao J; Xi ZX; Newman AH
Br J Pharmacol; 2020 Oct; 177(20):4796-4807. PubMed ID: 32851643
[TBL] [Abstract][Full Text] [Related]
2. The highly selective dopamine D
Jordan CJ; Humburg B; Rice M; Bi GH; You ZB; Shaik AB; Cao J; Bonifazi A; Gadiano A; Rais R; Slusher B; Newman AH; Xi ZX
Neuropharmacology; 2019 Nov; 158():107597. PubMed ID: 30974107
[TBL] [Abstract][Full Text] [Related]
3. The preferential dopamine D3 receptor antagonist S33138 inhibits cocaine reward and cocaine-triggered relapse to drug-seeking behavior in rats.
Peng XQ; Ashby CR; Spiller K; Li X; Li J; Thomasson N; Millan MJ; Mocaër E; Muńoz C; Gardner EL; Xi ZX
Neuropharmacology; 2009 Mar; 56(4):752-60. PubMed ID: 19136017
[TBL] [Abstract][Full Text] [Related]
4. Newly Developed Dopamine D
Jordan CJ; Humburg BA; Thorndike EB; Shaik AB; Xi ZX; Baumann MH; Newman AH; Schindler CW
J Pharmacol Exp Ther; 2019 Dec; 371(3):602-614. PubMed ID: 31562201
[TBL] [Abstract][Full Text] [Related]
5. The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats.
Xi ZX; Newman AH; Gilbert JG; Pak AC; Peng XQ; Ashby CR; Gitajn L; Gardner EL
Neuropsychopharmacology; 2006 Jul; 31(7):1393-405. PubMed ID: 16205781
[TBL] [Abstract][Full Text] [Related]
6. Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats.
Vorel SR; Ashby CR; Paul M; Liu X; Hayes R; Hagan JJ; Middlemiss DN; Stemp G; Gardner EL
J Neurosci; 2002 Nov; 22(21):9595-603. PubMed ID: 12417684
[TBL] [Abstract][Full Text] [Related]
7. PG01037, a novel dopamine D3 receptor antagonist, inhibits the effects of methamphetamine in rats.
Higley AE; Spiller K; Grundt P; Newman AH; Kiefer SW; Xi ZX; Gardner EL
J Psychopharmacol; 2011 Feb; 25(2):263-73. PubMed ID: 20142301
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D1 and D3 receptor interactions in cocaine reward and seeking in rats.
Galaj E; Harding W; Ranaldi R
Psychopharmacology (Berl); 2016 Dec; 233(23-24):3881-3890. PubMed ID: 27582181
[TBL] [Abstract][Full Text] [Related]
9. Dopamine D3 as well as D2 receptor ligands attenuate the cue-induced cocaine-seeking in a relapse model in rats.
Gál K; Gyertyán I
Drug Alcohol Depend; 2006 Jan; 81(1):63-70. PubMed ID: 16005579
[TBL] [Abstract][Full Text] [Related]
10. Dopamine D
You ZB; Bi GH; Galaj E; Kumar V; Cao J; Gadiano A; Rais R; Slusher BS; Gardner EL; Xi ZX; Newman AH
Neuropsychopharmacology; 2019 Jul; 44(8):1415-1424. PubMed ID: 30555159
[TBL] [Abstract][Full Text] [Related]
11. Blockade of D3 receptors by YQA14 inhibits cocaine's rewarding effects and relapse to drug-seeking behavior in rats.
Song R; Bi GH; Zhang HY; Yang RF; Gardner EL; Li J; Xi ZX
Neuropharmacology; 2014 Feb; 77():398-405. PubMed ID: 24176392
[TBL] [Abstract][Full Text] [Related]
12. YQA14: a novel dopamine D3 receptor antagonist that inhibits cocaine self-administration in rats and mice, but not in D3 receptor-knockout mice.
Song R; Yang RF; Wu N; Su RB; Li J; Peng XQ; Li X; Gaál J; Xi ZX; Gardner EL
Addict Biol; 2012 Mar; 17(2):259-73. PubMed ID: 21507153
[TBL] [Abstract][Full Text] [Related]
13. A novel dopamine D3 receptor antagonist YQA14 inhibits methamphetamine self-administration and relapse to drug-seeking behaviour in rats.
Chen Y; Song R; Yang RF; Wu N; Li J
Eur J Pharmacol; 2014 Nov; 743():126-32. PubMed ID: 25261038
[TBL] [Abstract][Full Text] [Related]
14. Differential ability of D1 and D2 dopamine receptor agonists to induce and modulate expression and reinstatement of cocaine place preference in rats.
Graham DL; Hoppenot R; Hendryx A; Self DW
Psychopharmacology (Berl); 2007 Apr; 191(3):719-30. PubMed ID: 16835769
[TBL] [Abstract][Full Text] [Related]
15. Selective dopamine D3 receptor antagonism by SB-277011A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost-variable-payoff fixed-ratio cocaine self-administration in rats.
Xi ZX; Gilbert JG; Pak AC; Ashby CR; Heidbreder CA; Gardner EL
Eur J Neurosci; 2005 Jun; 21(12):3427-38. PubMed ID: 16026480
[TBL] [Abstract][Full Text] [Related]
16. The effects of the novel DA D3 receptor antagonist SR 21502 on cocaine reward, cocaine seeking and cocaine-induced locomotor activity in rats.
Galaj E; Ananthan S; Saliba M; Ranaldi R
Psychopharmacology (Berl); 2014 Feb; 231(3):501-10. PubMed ID: 24037509
[TBL] [Abstract][Full Text] [Related]
17. Xie2-64, a novel CB
Jordan CJ; Feng ZW; Galaj E; Bi GH; Xue Y; Liang Y; McGuire T; Xie XQ; Xi ZX
Neuropharmacology; 2020 Oct; 176():108241. PubMed ID: 32712273
[TBL] [Abstract][Full Text] [Related]
18. Effects of selective dopamine D3 receptor partial agonist/antagonists on oxycodone self-administration and antinociception in monkeys.
Woodlief K; Allen MI; Cornelissen JC; Banks ML; Newman AH; Nader MA
Neuropsychopharmacology; 2023 Nov; 48(12):1716-1723. PubMed ID: 37118057
[TBL] [Abstract][Full Text] [Related]
19. Acute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats: role of dopamine D3 receptors.
Gilbert JG; Newman AH; Gardner EL; Ashby CR; Heidbreder CA; Pak AC; Peng XQ; Xi ZX
Synapse; 2005 Jul; 57(1):17-28. PubMed ID: 15858839
[TBL] [Abstract][Full Text] [Related]
20. Selective antagonism at dopamine D3 receptors attenuates cocaine-seeking behaviour in the rat.
Cervo L; Cocco A; Petrella C; Heidbreder CA
Int J Neuropsychopharmacol; 2007 Apr; 10(2):167-81. PubMed ID: 16426478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
